Cite
Kommalapati A, Sikder S, Tella SH. Immune Check Point Inhibitors in Cancer Therapy: Beware of "Friendly Fire" Effect. Res Rev J Hosp Clin Pharm. 2017;3(2):5-6
Kommalapati, A., Sikder, S., & Tella, S. H. (2017). Immune Check Point Inhibitors in Cancer Therapy: Beware of "Friendly Fire" Effect. Research & reviews. Journal of hospital and clinical pharmacy, 3(2), 5-6.
Kommalapati, Anuhya, et al. "Immune Check Point Inhibitors in Cancer Therapy: Beware of "Friendly Fire" Effect." Research & reviews. Journal of hospital and clinical pharmacy vol. 3,2 (2017): 5-6.
Kommalapati A, Sikder S, Tella SH. Immune Check Point Inhibitors in Cancer Therapy: Beware of "Friendly Fire" Effect. Res Rev J Hosp Clin Pharm. 2017 Jul;3(2):5-6. Epub 2017 Jun 08. PMID: 29291253; PMCID: PMC5744671.
Copy
Download .nbib